MUSCAT: Nakorn Patana Company Limited, a Thailand-based company operating in pharmaceutical and medicine manufacturing, has been briefed on investment opportunities in the Sultanate of Oman.
This came during a meeting with Issa bin Abdullah Al-Alawi, the Sultanate’s ambassador to the Kingdom of Thailand, on Tuesday with the CEO of Nakorn Group, a leading and giant in pharmaceutical and medicine manufacturing.
The Sultanate of Oman embassy in Bangkok tweeted that during the meeting, the company and its business were identified, and the possibility of investing in the Sultanate of Oman was discussed.
Read More
- His Majesty Sultan Haitham pardons 344 prisoners ahead of Oman’s National Day
- ROP urges public to celebrate Oman National Day responsibly
- Oman issues new telecoms and IT law, renames regulator
- Oman’s CPA recovers RO 4,750 for consumers in Al Suwaiq vehicle dispute
- Oman marks National Day with economic gains, rising global competitiveness and major development projects





